New York, Sept. 25, 2017 --
Persistence Market Research has carried out a detailed market research on next-generation IV infusion pumps and has presented vital insights based on the market analyses in its research publication titled “Next-Generation IV Infusion Pumps Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”. This research report covers various macro-economic aspects influencing the growth of the next generation IV infusion pumps market along with various trends, opportunities, restraints and drivers impacting the market. These impacting factors are scrutinized across important regions considering all major market segments.
The global next-generation IV infusion pumps market has been thoroughly analyzed and is anticipated to grow at a robust CAGR of 5.4% throughout the period of forecast 2017-2025. The global market is estimated to reach a value of about US$ 3.2 Bn in 2025 from a value of around US$ 2 Bn in 2016. This market has witnessed a positive growth path since 2012 and it is poised to continue over the following years.
Global Market Research Report Overview on Next-generation IV Infusion Pumps @ https://www.persistencemarketresearch.com/market-research/next-generation-iv-infusion-pumps-market.asp
Expanding production base for smart PCA, ambulatory and syringe pumps in developing economies and rising adoption of smart pumps with huge drug libraries are opportunities that can be tapped by players involved in the global next-generation IV infusion pumps market. Emerging economies offer high opportunities as they register high rate of spread of chronic diseases. The advancements in IV infusion pumps systems, increasing research and development infrastructure due to rising investments and expenditure on research and development, favorable reimbursement for infusion therapy, rising demand for ambulatory infusion pumps, increasing strategic collaborations among leading players, improvement in distribution channel, ease in FDA approvals and clearance, strong government support for start-ups, expanding production capacity and extension of product line coupled with expanding medical device infrastructure and growing adoption of advanced medical devices have strongly supported the growth of the next-generation IV infusion pumps market. Medicine dispensing errors, product recalls due to product errors, lack of skilled personnel and lack of standard usage guidelines are few aspects which pull the adoption of next-generation IV infusion pumps thus having a negative impact on the global next-generation IV infusion pumps market.
A sample of this report is available upon request@ https://www.persistencemarketresearch.com/samples/15781
Global Next-Generation IV Infusion Pumps Market: Segmental Highlights
The global next-generation IV infusion pumps market has been categorized by product type, by application, by end user and by region.
By region, Asia Pacific is expected to witness high growth as compared to other regions, and is poised to reach a significant market share with a high CAGR of 7.8% throughout the period of forecast 2017-2025. North America region stays ahead with respect to market value to dominate the global next-generation IV infusion pumps market by region followed by Europe.
Chemotherapy segment by application is the fastest growing segment and is expected to reflect high market valuation by the end of 2025. This segment is projected to grow at a CAGR of 7.1% throughout the forecast period to attain an estimated value of about US$ 1.1 Bn in 2025.
Hospitals segment by end user dominates the global market and also poised to reflect a high CAGR of 6.0% during the assessment period due to rise in adoption of infusion pumps in hospitals.
Large volumetric infusion systems to lead the global next-generation IV infusion pumps market by product type to reach a market value of about US$ 1.1 Bn in 2025. Electronic ambulatory infusion systems product segment is poised to show high potential in the coming years.
View Report Table of Contents, Figures, and Tables@ https://www.persistencemarketresearch.com/market-research/next-generation-iv-infusion-pumps-market/toc
Global Next-Generation IV Infusion Pumps Market: Competitive Landscape
The global next-generation IV infusion pumps market research report covers key players involved in the market such as B. Braun Melsungen AG., Becton, Dickinson Company, Fresenius Kabi AG, Terumo Corporation, Medtronic Plc., Baxter International Inc., Hospira, Inc., iRadimed Corporation, Zyno Medical, Nipro Corporation, Ambu A/S, Summit Medical Products, Inc., Smiths Medical, vTitan and Gamastech s.r.l.
Global Next-generation IV Infusion Pumps Market Report is Available for US$ 4,900
Persistence Market Research Overview
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research U.S. Sales Office: 305 Broadway, 7th Floor New York City, NY 10007 +1-646-568-7751 United States USA - Canada Toll-Free: 800-961-0353 Email: [email protected]


Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



